While its proposed (but never thoroughly characterized) actions on vestibular symptoms and vertigo may be due to the inhibition of Cav1.3 channels in vestibular hair cells, cinnarizine cannot be considered Cav1.3-selective. This evidence concerns the gene CACNA1D and Vertigo.